33 Development of a clinical ex vivo assay for the assessment of therapeutic CD28 costimulatory pathway engagement

• Jing Yang,
• Gary Means,
• Pamela Holland,
• Chelsea Gudgeon,
• Mark Maurer,
• Sherri Mudri,
• Lori Blanchfield,
• Stacey Dillon,
• Zelanna Goldberg,
• Stanford Peng

Affiliations

Jing Yang

Department of Neurology, Laboratory of Neurodegenerative Disorders, Rare disease center, West China Hospital, Sichuan University, Chengdu, China

Gary Means

Aff510 grid.438014.aSeattle Genetics, Inc. Bothell WA USA

Pamela Holland

3Surface Oncology, Inc., Cambridge, MA, USA

Chelsea Gudgeon

Alpine Immune Sciences, Inc., Seattle, WA, USA

Mark Maurer

Alpine Immune Sciences, Inc., Seattle, WA, USA

Sherri Mudri

Alpine Immune Sciences, Inc., Seattle, WA, USA

Lori Blanchfield

Alpine Immune Sciences, Inc., Seattle, WA, USA

Stacey Dillon

Alpine Immune Sciences, Inc., Seattle, WA, USA

Zelanna Goldberg

Alpine Immune Sciences, Inc., Seattle, WA, USA

Stanford Peng

Alpine Immune Sciences, Inc., Seattle, WA, USA